{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:03:58Z","timestamp":1789693438431,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["2022\\u20130405-JCC-0319"],"award-info":[{"award-number":["2022\\u20130405-JCC-0319"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["26JRRA739"],"award-info":[{"award-number":["26JRRA739"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cellsig.2026.112841","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:42:45Z","timestamp":1787438565000},"page":"112841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["DLGAP5 enhances chemotherapy resistance in pancreatic ductal adenocarcinoma by regulating glycolysis through MYC"],"prefix":"10.1016","volume":"148","author":[{"given":"Pengxian","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2026.112841_bb0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112841_bb0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamasurg.2023.7872","article-title":"Implementation of best practices in pancreatic cancer care in the Netherlands: a stepped-wedge randomized clinical trial","volume":"159","author":"Mackay","year":"2024","journal-title":"JAMA Surg."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112841_bb0015","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112841_bb0020","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/bjs\/znaa146","article-title":"Effect of centralization and regionalization of pancreatic surgery on resection rates and survival","volume":"108","author":"Latenstein","year":"2021","journal-title":"Br. J. Surg."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112841_bb0025","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"10485","key":"10.1016\/j.cellsig.2026.112841_bb0030","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112841_bb0035","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jamasurg.2020.2286","article-title":"Response and survival associated with first-line FOLFIRINOX vs gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma","volume":"155","author":"Perri","year":"2020","journal-title":"JAMA Surg."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112841_bb0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1615\/CritRevOncog.2019031641","article-title":"Gemcitabine: a review of chemoresistance in pancreatic cancer","volume":"24","author":"Sarvepalli","year":"2019","journal-title":"Critical Reviews\u2122 in Oncogenesis"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112841_bb0045","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2021.09.022","article-title":"Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence","volume":"162","author":"Dreyer","year":"2022","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112841_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01169-7","article-title":"Metabolism of pancreatic cancer: paving the way to better anticancer strategies","volume":"19","author":"Qin","year":"2020","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112841_bb0055","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cellsig.2026.112841_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109521","article-title":"Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine","volume":"121","author":"Dai","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112841_bb0065","first-page":"4470","article-title":"ENO1 silencing impaires hypoxia-induced gemcitabine chemoresistance associated with redox modulation in pancreatic cancer cells","volume":"11","author":"Wang","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.cellsig.2026.112841_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216696","article-title":"Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy","volume":"587","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112841_bb0075","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1083\/jcb.200511132","article-title":"HURP controls spindle dynamics to promote proper interkinetochore tension and efficient kinetochore capture","volume":"173","author":"Wong","year":"2006","journal-title":"J. Cell Biol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112841_bb0080","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00384-019-03339-6","article-title":"Prognostic value of DLGAP5 in colorectal cancer","volume":"34","author":"Branchi","year":"2019","journal-title":"Int. J. Colorectal Dis."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112841_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080789","article-title":"Silencing of DLGAP5 by siRNA significantly inhibits the proliferation and invasion of hepatocellular carcinoma cells","volume":"8","author":"Liao","year":"2013","journal-title":"PLoS One."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112841_bb0090","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2021.10680","article-title":"Knockdown of DLGAP5 suppresses cell proliferation, induces G2\/M phase arrest and apoptosis in ovarian cancer","volume":"22","author":"Zhang","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cellsig.2026.112841_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-020-01474-7","article-title":"Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancer","volume":"20","author":"Ke","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112841_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02008-9","article-title":"Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112841_bb0105","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.7150\/thno.102730","article-title":"DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilization","volume":"15","author":"Deng","year":"2025","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112841_bb0110","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/1541-7786.MCR-12-0699","article-title":"Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survival","volume":"11","author":"Burkhart","year":"2013","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112841_bb0115","doi-asserted-by":"crossref","DOI":"10.1080\/08941939.2022.2129884","article-title":"Pancreatic cancer: a review of current treatment and novel therapies","volume":"36","author":"Kolbeinsson","year":"2023","journal-title":"J. Invest. Surg."},{"key":"10.1016\/j.cellsig.2026.112841_bb0120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejca.2021.10.023","article-title":"Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: a meta-analysis of randomised controlled trials","volume":"160","author":"van Dam","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112841_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07426-8","article-title":"Clinical characteristics and blood\/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel","volume":"20","author":"Blomstrand","year":"2020","journal-title":"BMC Cancer."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112841_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13304-021-01186-1","article-title":"Neoadjuvant therapy for pancreatic cancer","volume":"74","author":"Gugenheim","year":"2022","journal-title":"Updates Surg."},{"key":"10.1016\/j.cellsig.2026.112841_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","article-title":"How the Warburg effect supports aggressiveness and drug resistance of cancer cells?","volume":"38","author":"Icard","year":"2018","journal-title":"Drug Resist. Updat."},{"issue":"8021","key":"10.1016\/j.cellsig.2026.112841_bb0140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","article-title":"NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance","volume":"631","author":"Chen","year":"2024","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112841_bb0145","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41388-023-02932-y","article-title":"DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11","volume":"43","author":"Zhou","year":"2024","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112841_bb0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","article-title":"MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart Gemcitabine resistance to pancreatic cancer","volume":"32","author":"Shukla","year":"2017","journal-title":"Cancer Cell."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112841_bb0155","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canlet.2014.09.003","article-title":"2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy","volume":"355","author":"Zhang","year":"2014","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112841_bb0160","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cmet.2017.09.009","article-title":"MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation","volume":"26","author":"Lee","year":"2017","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112841_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01967-6","article-title":"MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance","volume":"8","author":"Farrell","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112841_bb0170","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.gastro.2021.09.017","article-title":"Mucin 5AC serves as the nexus for \u03b2-catenin\/c-MYC interplay to promote glutamine dependency during pancreatic cancer chemoresistance","volume":"162","author":"Ganguly","year":"2022","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112841_bb0175","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/14728222.2021.2015321","article-title":"Glycometabolic rearrangements-aerobic glycolysis in pancreatic ductal adenocarcinoma (PDAC): roles, regulatory networks, and therapeutic potential","volume":"25","author":"Zhang","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.cellsig.2026.112841_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.851512","article-title":"c-Myc-PD-L1 axis sustained gemcitabine-resistance in pancreatic cancer","volume":"13","author":"Yao","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112841_bb0185","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12943-024-02128-2","article-title":"Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer","volume":"23","author":"Xie","year":"2024","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112841_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113808","article-title":"UDP-glucose dehydrogenase supports autophagy-deficient PDAC growth via increasing hyaluronic acid biosynthesis","volume":"43","author":"Fan","year":"2024","journal-title":"Cell Rep."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:16:06Z","timestamp":1789690566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826004997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":38,"alternative-id":["S0898656826004997"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112841","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DLGAP5 enhances chemotherapy resistance in pancreatic ductal adenocarcinoma by regulating glycolysis through MYC","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112841"}}